|
|
| (57 intermediate revisions by 4 users not shown) |
| Line 1: |
Line 1: |
| __NOEDITSECTION____NOTOC__
| | #REDIRECT [[Metoprolol tartrate]] |
| {{Metoprolol}}
| |
| {{CMG}}
| |
| | |
| {| style="border: 3px solid #696969;"
| |
| | style="background: #000000; border: 0px; padding: 20px 20px; width: 800px;" |
| |
| <center>
| |
| <font color="#F8F8FF">'''WARNING'''</font>
| |
| </center>
| |
| | |
| <center>
| |
| <font color="#F8F8FF" size="1">''See full prescribing information for complete boxed warning.''</font>
| |
| </center>
| |
| | |
| | |
| <b><font color="#F8F8FF">
| |
| Ischemic Heart Disease: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred. When discontinuing chronically administered Lopressor, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1-2 weeks and the patient should be carefully monitored. If angina markedly worsens or acute coronary insufficiency develops, Lopressor administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken. Patients should be warned against interruption or discontinuation of therapy without the physician’s advice. Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue Lopressor therapy abruptly even in patients treated only for hypertension.
| |
| </font></b>
| |
| |}
| |
| | |
| ===[[Lopressor indications and usage|Indications and Usage]]===
| |
| ===[[Lopressor dosage and administration|Dosage and Administration]]===
| |
| ===[[Lopressor dosage forms and strengths|Dosage Forms and Strengths]]===
| |
| ===[[Lopressor contraindications|Contraindications]]===
| |
| ===[[Lopressor warnings and precautions|Warnings and Precautions]]===
| |
| ===[[Lopressor adverse reactions|Adverse Reactions]]===
| |
| ===[[Lopressor drug interactions|Drug Interactions]]===
| |
| ===[[Lopressor use in specific populations|Use in Specific Populations]]===
| |
| ===[[Lopressor overdosage|Overdosage]]===
| |
| ===[[Lopressor description|Description]]===
| |
| ===[[Lopressor clinical pharmacology|Clinical Pharmacology]]===
| |
| ===[[Lopressor nonclinical toxicology|Nonclinical Toxicology]]===
| |
| ===[[Lopressor clinical studies|Clinical Studies]]===
| |
| ===[[Lopressor how supplied storage and handling|How Supplied/Storage and Handling]]===
| |
| ===[[Lopressor patient counseling information|Patient Counseling Information]]===
| |
| ===[[Lopressor labels and packages|Labels and Packages]]===
| |
| ===[[Lopressor pill images|Pill Images]]===
| |
| | |
| [[Category:Antianginals]]
| |
| [[Category:Antiarrhythmic agents]]
| |
| [[Category:Antihypertensive agents]]
| |
| [[Category:Antimigraine drugs]]
| |
| [[Category:Beta blockers]]
| |
| [[Category:Cardiovascular Drugs]]
| |